Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 10Hodgkin Disease 5Lymphoma 3Sarcoma 2Thyroid Neoplasms 1Recurrence 1Neoplasm Metastasis 1Leiomyosarcoma 1Carcinoma, Medullary 1

Interventions

vandetanib 2rovalpituzumab tesirine 1pentetreotide 1lenvatinib 1cabozantinib 1Sorafenib 1Octreotide 1Lithium Carbonate 1Irinotecan 1Imatinib Mesylate 1Dexamethasone 1Dacarbazine 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Medullary × Dacarbazine × Clear all
NCT00354523 2014-12-17

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

M.D. Anderson Cancer Center

Phase 1/2 Terminated
21 enrolled
Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡